Heron Therapeutics
HRTX
#8682
Rank
NZ$0.33 B
Marketcap
NZ$1.78
Share price
5.00%
Change (1 day)
-44.61%
Change (1 year)

Heron Therapeutics (HRTX) Fails to deliver data

Key failure to deliver metrics for Heron Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Heron Therapeutics (HRTX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Heron Therapeutics (HRTX) - since 2014

Volume in USD (price x number of shares), data since 2014

Heron Therapeutics (HRTX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026NZ$1.16 M-73.66%
2025NZ$4.41 M-35.17%
2024NZ$6.81 M-34.07%
2023NZ$10.33 M-72.07%
2022NZ$37 M400.43%
2021NZ$7.39 M-54.24%
2020NZ$16.15 M-59.1%
2019NZ$39.5 M107.62%
2018NZ$19.02 M-26.02%
2017NZ$25.71 M-47.54%
2016NZ$49.03 M17.09%
2015NZ$41.87 M1264.2%
2014NZ$3.06 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
SurModics
SRDX
N/ANZ$7.26 M๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
NZ$0.48 MNZ$6.55 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$5.24 MNZ$14.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$3.35 MNZ$46.3 M๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
N/ANZ$0.05 M๐Ÿ‡บ๐Ÿ‡ธ USA